Literature DB >> 23077121

False daptomycin-nonsusceptible MIC results by Microscan panel PC 29 relative to Etest results for Staphylococcus aureus and enterococci.

Elizabeth L Palavecino1, Jacqueline M Burnell.   

Abstract

This study correlated the daptomycin MIC results obtained by Microscan and by Etest in Staphylococcus aureus and enterococci and found that the Microscan panel GP 29 had a high rate of false nonsusceptible results. Of the isolates interpreted as nonsusceptible by Microscan, 87% of Staphylococcus aureus, 90% of Enterococcus faecalis, and 88% of Enterococcus faecium isolates were interpreted as susceptible by Etest. In turn, Etest also has false nonsusceptible results compared to reference methods.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23077121      PMCID: PMC3536226          DOI: 10.1128/JCM.01721-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  9 in total

1.  Correlation between vancomycin and daptomycin MIC values for methicillin-susceptible and methicillin-resistant Staphylococcus aureus by 3 testing methodologies.

Authors:  Rebecca A Keel; Christina A Sutherland; Jaber Aslanzadeh; David P Nicolau; Joseph L Kuti
Journal:  Diagn Microbiol Infect Dis       Date:  2010-11       Impact factor: 2.803

2.  Diminished susceptibility to daptomycin accompanied by clinical failure in a patient with methicillin-resistant Staphylococcus aureus bacteremia.

Authors:  David Hirschwerk; Christine C Ginocchio; Maureen Bythrow; Susan Condon
Journal:  Infect Control Hosp Epidemiol       Date:  2006-02-23       Impact factor: 3.254

3.  Evidence for daptomycin Etest lot-related MIC elevations for Staphylococcus aureus.

Authors:  Lawrence Friedrich; Grace Thorne; Judith N Steenbergen; Diane Anastasiou; Laura Koeth
Journal:  Diagn Microbiol Infect Dis       Date:  2009-09-16       Impact factor: 2.803

4.  Development of Daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus.

Authors:  M K Hayden; K Rezai; R A Hayes; K Lolans; J P Quinn; R A Weinstein
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

5.  Determination of vancomycin and daptomycin MICs by different testing methods for methicillin-resistant Staphylococcus aureus.

Authors:  Mark C Kruzel; Cole T Lewis; Kerry J Welsh; Evan M Lewis; Nicola E Dundas; John F Mohr; Lisa Y Armitige; Audrey Wanger
Journal:  J Clin Microbiol       Date:  2011-03-30       Impact factor: 5.948

6.  Comparison of daptomycin Etest MICs on Mueller Hinton, IsoSensitest and brain heart infusion agars from Europe against 20 Staphylococcus aureus isolates.

Authors:  L M Koeth; J M DiFranco
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-06-22       Impact factor: 3.267

7.  Emergence of daptomycin-resistant VRE: experience of a single institution.

Authors:  Mini Kamboj; Nina Cohen; Kathleen Gilhuley; N Esther Babady; Susan K Seo; Kent A Sepkowitz
Journal:  Infect Control Hosp Epidemiol       Date:  2011-04       Impact factor: 3.254

8.  Nine-hospital study comparing broth microdilution and Etest method results for vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus.

Authors:  Helio S Sader; Paul R Rhomberg; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2009-04-27       Impact factor: 5.191

9.  Daptomycin nonsusceptible enterococci: an emerging challenge for clinicians.

Authors:  Theodoros Kelesidis; Romney Humphries; Daniel Z Uslan; David A Pegues
Journal:  Clin Infect Dis       Date:  2011-01-15       Impact factor: 20.999

  9 in total
  5 in total

1.  Evaluation of the Accelerate Pheno System: Results from Two Academic Medical Centers.

Authors:  Joseph D Lutgring; Cassiana Bittencourt; Erin McElvania TeKippe; Dominick Cavuoti; Rita Hollaway; Eileen M Burd
Journal:  J Clin Microbiol       Date:  2018-03-26       Impact factor: 5.948

2.  Use of online tools for antimicrobial resistance prediction by whole-genome sequencing in methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE).

Authors:  Ahmed Babiker; Mustapha M Mustapha; Marissa P Pacey; Kathleen A Shutt; Chinelo D Ezeonwuka; Sara L Ohm; Vaughn S Cooper; Jane W Marsh; Yohei Doi; Lee H Harrison
Journal:  J Glob Antimicrob Resist       Date:  2019-04-18       Impact factor: 4.035

Review 3.  A current perspective on daptomycin for the clinical microbiologist.

Authors:  Romney M Humphries; Simon Pollett; George Sakoulas
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

4.  Rapid emergence of daptomycin resistance in clinical isolates of Corynebacterium striatum… a cautionary tale.

Authors:  E McElvania TeKippe; B S Thomas; G A Ewald; S J Lawrence; C-A D Burnham
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-06-28       Impact factor: 3.267

5.  Systematic evaluation of commercial susceptibility testing methods for determining the in vitro activity of daptomycin versus Staphylococcus aureus and Enterococci.

Authors:  Thomas J Kirn; Elizabeth Onyeaso; Madiha Syed; Melvin P Weinstein
Journal:  J Clin Microbiol       Date:  2014-03-19       Impact factor: 5.948

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.